Lundbeck Still Assessing Future Of Antipsychotic After Phase III Failure, Says CEO

 
• By Jo Shorthouse
  
Video interview
Lundbeck CEO Deborah Dunsire Talks To Scrip At BIO-Europe 2018 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapy Areas